This paper used the Sleeping Beauty transposon insertional mutagenesis system to identify genes that accelerate the development of KrasG12D-induced pancreatic ductal adenocarcinoma (PDA) in mice. In more than 50% of the tumours the Usp9x gene, which encodes a deubiquitylase, was inactivated. Analyses of human PDA samples indicated that low USP9X mRNA and protein levels correlate with a poor prognosis. Interestingly, treatment of human PDA cell lines with chromatin-modifying drugs, such as 5-aza-2′-deoxycytidine, increased USP9X expression, suggesting that epigenetic therapies might be appropriate for some patients with PDA.
ORIGINAL RESEARCH PAPER
Pérez-Mancera, P. A. et al. The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma. Nature 29 Apr 2012 (doi:10.1038/nature11114)
Rights and permissions
About this article
Cite this article
McCarthy, N. Cooperation. Nat Rev Cancer 12, 374 (2012). https://doi.org/10.1038/nrc3296
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrc3296